• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. Little data exists about how long-term exposure to these medications may affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the benefits of taking them against the potential risks to the fetus. Physicians don't have the necessary data to provide clear recommendations but they can provide information about the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have a significantly increased risk of fetal heart malformations or major structural birth defects. Researchers conducted a large, population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who can prescribe medication for adhd had taken stimulants in the early stages of pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to ensure that the classification was accurate and to eliminate any bias.

However, the researchers' study had its limitations. Most important, they were unable to distinguish the effects of the medication from the effects of the disorder at hand. This makes it difficult for researchers to determine whether the few associations observed between the exposed groups were due to the use of medication or if they were confounded by comorbidities. In addition the study did not study long-term offspring outcomes.

The study did find that infants whose mothers took ADHD medications during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or Genetic testing for adhd medications had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medication during pregnancies in the early stages may be offset by the greater benefits for mother and baby from continuing treatment for the woman's condition. Physicians should discuss this with their patients and, if possible, help them develop strategies to improve coping skills that can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the issue of whether to keep or end treatment during pregnancy is a question that doctors are having to have to face. The majority of these decisions are made in the absence of clear and authoritative evidence regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what the research suggests about the subject as well as their best medication for adhd combined type judgment for each individual patient.

Particularly, the subject of potential risks for the infant can be difficult. Many studies on this topic are based on observational data rather than controlled research, and their conclusions are often contradictory. The majority of studies focus on live births, which can underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study discussed in the journal club addresses these limitations, by examining both data on live and deceased births.

Conclusion: While some studies have found an association between ADHD medications and certain birth defects, other studies have not established a link. The majority of studies show a neutral, or even somewhat negative, impact. Therefore an accurate risk-benefit analysis must be done in each situation.

For women suffering from ADHD and ADD, the decision to discontinue medication is difficult if not impossible. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. A decrease in medication could affect the ability to safely drive and complete work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy should educate family members, colleagues, and acquaintances about the condition, the impact on daily functioning and the benefits of keeping the current treatment. It can also help women feel supported in her decision. It is important to remember that certain drugs can pass through the placenta, therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug can be transferred to the child.

Birth Defects Risk

As the use and misuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential adverse effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. Researchers utilized two massive data sets to study more than 4.3 million pregnancy and determine whether stimulant medications caused birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The researchers of the study found no connection between early use of medication and other congenital anomalies, like facial clefting, or club foot. The findings are in line with previous studies showing an increase, but not significant, in the risk of developing cardiac malformations among women who started taking ADHD medications before the birth of their child. The risk was higher in the latter half of pregnancy, when a lot of women decide to stop taking their ADHD medication.

Women who took ADHD medication in the first trimester were more likely require a caesarean birth, have an insufficient Apgar after delivery, and have a baby who needed breathing assistance at birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who did not have other medical issues that could have contributed to these findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. The researchers advise that while discussing risks and benefits are important, the choice regarding whether or not to stop medication should be according to the severity of each woman's ADHD symptoms and her requirements.

The authors caution that, even though stopping the medication is a possibility to look into, it is not advised due to the high rate depression and other mental disorders among women who are pregnant or have recently given birth. Research has also shown that women who stop taking their medications will have a difficult time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience to become a mother. Women with Adhd Medication Guide, Squareblogs.Net, who have to manage their symptoms while attending physician appointments and making preparations for the arrival of a baby and getting used to new routines at home are often faced with a number of difficulties. Many women decide to continue taking their ADHD medication during pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medications passes through breast milk in low amounts. However, the frequency of exposure to medication by the infant can differ based on the dosage, frequency it is taken and the time of the day it is administered. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn isn't fully known.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant medication during the pregnancy of a woman. This is a difficult decision for the mother, who must weigh the advantages of continuing her medication against the risk to the foetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and if they are taking or planning to take medication during the perinatal period.

Many studies have shown that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. In the end, many patients choose to do so, and in consultation with their doctor they have found that the benefits of maintaining their current medication outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons for continuing treatment. This includes non stimulant adhd medication-pharmacological methods. Psychoeducation is also needed to help pregnant women suffering from ADHD recognize the signs and the underlying disorder. They should also be informed about treatment options and reinforce strategies for coping. This should be a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, and monitoring for indicators of deterioration, and, if necessary, adjustments to the medication regime.